Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant’s patents for its blockbuster MS drug Gilenya.
K&L Gates boosts IP team by snapping up Herbert Smith Freehills partner
ASIC accuses Westpac of insider trading over Ausgrid privatisation
Banking royal commission silk Rowena Orr named Victoria’s solicitor-general
Monash IVF faces potential class action over ‘ineffective’ genetic tests
Forge liquidators can expand insider trading case against Clough, directors
AUSTRAC orders Australian Military Bank to improve anti-money laundering compliance
YouTuber Jordan Shanks says NSW Deputy Premier threatened to sue for defamation
Former QC, now judge hit with costs in negligent advice case
Judge mulling $38.4M Estia settlement hears class closure rulings ‘plainly wrong’
A judge weighing a $38.4 million settlement in a shareholder class action against aged care provider Estia Health has been told that two NSW Court of Appeal judgments barring class closure were “plainly wrong”, but in deciding whether to lock group members out of the settlement the judge says he won’t need to grapple with the landmark rulings.